Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Gross Profit (2022 - 2025)

Historic Gross Profit for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $503855.0.

  • bioAffinity Technologies' Gross Profit fell 4464.52% to $503855.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 4247.04%. This contributed to the annual value of $3.4 million for FY2024, which is 32679.17% up from last year.
  • bioAffinity Technologies' Gross Profit amounted to $503855.0 in Q3 2025, which was down 4464.52% from $252881.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Gross Profit peaked at $989942.0 during Q2 2024, and registered a low of $834.0 during Q1 2023.
  • Moreover, its 4-year median value for Gross Profit was $369309.0 (2025), whereas its average is $386926.4.
  • As far as peak fluctuations go, bioAffinity Technologies' Gross Profit soared by 9977410.07% in 2024, and later plummeted by 7445.5% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Gross Profit stood at $2171.0 in 2022, then surged by 25164.72% to $548497.0 in 2023, then rose by 17.67% to $645427.0 in 2024, then dropped by 21.93% to $503855.0 in 2025.
  • Its Gross Profit stands at $503855.0 for Q3 2025, versus $252881.0 for Q2 2025 and $485737.0 for Q1 2025.